FundedIQ
Healthcare

Noteless

Noteless offers an AI platform that turns doctor-patient talks into structured medical notes, supporting multiple specialties and languages.

www.noteless.no Oslo, Norway 11-50 employees
Total raised
$8.2M
Latest round: +99% of prior total
Rounds
2
Latest
Seed
Nov 2025

Noteless offers an AI platform that turns doctor-patient talks into structured medical notes, supporting multiple specialties and languages.

Noteless has raised $8.2M across 2 rounds. Its most recent round was a Seed of $4.1M in Nov 2025. Full funding history, investors, and team are detailed below.

Funding history

2 rounds · 1 visible Unlock with plan

2 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Nov 30, 2025
Seed
$4.1M

Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Noteless is featured in

Similar companies

MedReddie

MedReddie simplifies clinical procurement and market research to drive the future of healthcare.

Seed $1.1M
Gosta Labs

Gosta Labs focuses on building healthcare-specialized machine learning models to drive improved efficiency and outcomes.

Seed $8.7M
MPC Container Ships

MPCC acquires and operates Feeder container vessels between 1,000 and 3,000 TEU. These vessels are essential for the growing intra-regional trade. Second-hand Feeder vessels are trading near all-time lows and at large discounts to newbuild parity prices. This has enabled MPCC to create a sizeable fleet at attractive prices with some of the lowest cash operating costs in the industry.

Series Unknown $10.8M
Zelluna Immunotherapy

Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on the development of TCR based immunotherapies. Our goal is to revolutionize cancer therapy by developing TCR based therapies with the potential to treat a wide range of cancer types and patients. Zelluna’s core asset is a wide range of TCRs isolated from patients who exhibited long-term survival following inclusion in peptide based cancer vaccine trials initiated by Prof Gustav Gaudernack and conducted by investigators at the Norwegian Radium Hospital/Oslo University Hospital. Currently the company has several TCRs in different stages of development. We are a member of Oslo Cancer Cluster (Norwegian Centre of Expertise), a member organization for Norwegian and International stakeholders within cancer research and development. Oslo Cancer Cluster has members from the biotechnology industry, the government, patient organizations, research institutions and hospitals. Zelluna is located at the Oslo Cancer Cluster Innovation Park, next to the Norwegian Radium Hospital/Oslo University Hospital, the Department for Cellular Therapy and one of Europe’s largest academic certified GMP facilities for cellular products.

Series Unknown $1.6M
Hofseth BioCare

Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through inventive creation innovation and coordinated factors, they safeguard the nature of protein, calcium and oil extricated from fish. This innovation is exclusive to their organization.

Series Unknown $14.6M
Norwegian Property

Norwegian Property is a commercial property company that offers property development and property management services. Additionally, they provide financial and transaction solutions.

Series Unknown $73.8M
Maritime Robotics

Maritime Robotics is a leading provider of cutting-edge unmanned solutions for maritime operations in challenging environments. They work closely with civilian, governmental, and military partners to develop technology that is high-quality, cost-effective, and reduces risks. Their systems can operate both in the air and on the surface, collecting a wide range of data from the atmosphere to the ocean floor. Maritime Robotics believes that the future of maritime operations will increasingly involve unmanned data gathering, setting new industry standards and expanding operational capabilities. Based in Trondheim, Norway, their team of skilled engineers and staff is ready to provide information, resources, and assistance to help clients find the best solution for their maritime needs.

Series Unknown $32.4M
Circio

Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging diseases. Their goal is to use vector-based technology to create a new type of circRNA medicines. They are working with Prof Michael Uhlin and his team at the Karolinska Institutet in Stockholm to develop advanced RNA therapeutics. Additionally, the company is conducting two collaborative clinical trials for a mutant RAS cancer vaccine program in the USA and Norway. They are also exploring financing options for a phase 2 study of ONCOS-102, a genetically modified oncolytic adenovirus.

Series Unknown $31.5M
Magnora Data Center

Magnora Data Center is a developer and operator of data center infrastructure. The company focuses on specific facilities with energy capacities ranging between 20 and 150 megawatts. The firm advances these projects from the initial greenfield stage directly to the ready-to-build phase. The organization provides physical computing environments to support artificial intelligence workloads and standard data processing requirements.

Series Unknown $69.8M
PolarDC Group

PolarDC Group is an operator of HPC data center facilities, providing a full-service offer from design to first implementation and continuing operations, and prioritizing sustainability.

Series Unknown $932M
Cloudgeni

Cloudgeni is an AI-Native cloud operations platform that gives engineering teams continuous control over their cloud environments. It unifies visibility, security, compliance, and automation across infrastructure, helping teams prevent risk, reduce operational complexity, and scale cloud operations safely. Cloudgeni enables organizations to move faster in the cloud with built-in intelligence and guardrails.

Pre-Seed $1.0M
REC Silicon ASA

REC Silicon ASA is a leading producer of advanced silicon materials, supplying high-purity polysilicon and silicon gases to the solar and electronics industries worldwide. We combine over 30 years' experience and best-in-class proprietary technology to deliver on customer expectations. Our two U.S. based plants have a capacity of more than 20,000 MT high-purity polysilicon. REC Silicon is headquartered in Fornebu, Norway and listed on the Oslo stock exchange under the ticker: REC.

Series Unknown $10.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.